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BACKGROUND: Sustainability—the routinization and
institutionalization of processes that improve the qual-
ity of healthcare—is difficult to achieve and not often
studied.
OBJECTIVE: To evaluate the sustainability of increased
rates of HIV testing after implementation of a multi-
component intervention in two Veterans Health Admin-
istration healthcare systems.
DESIGN: Quasi-experimental implementation study in
which the effect of transferring responsibility to conduct
the provider education component of the intervention
from research to operational staff was assessed.
PATIENTS: Persons receiving healthcare between 2005
and 2006 (intervention year) and 2006 and 2007
(sustainability year).
MEASUREMENTS: Monthly HIV testing rate, stratified
by frequency of clinic visits.
RESULTS: The monthly adjusted testing rate increased
from 2% at baseline to 6% at the end intervention year
and then declined reaching 4% at the end of the
sustainability year. However, the stratified, visit-specific
testing rate for persons newly exposed to the interven-
tion (i.e., having their first through third visits during
the study period) increased throughout the intervention
and sustainability years. Increases in the proportion of
visits by patients who remained untested despite
multiple, prior exposures to the intervention accounted
for the aggregate attenuation of testing during the
sustainability year. Overall, the percentage of patients
who received an HIV test in the sustainability year was
11.6%, in the intervention year 11.1%, and in the pre-
intervention year 5.0%
CONCLUSIONS: Provider education combined with
informatics and organizational support had a sustain-
able effect on HIV testing rates. The effect was most
pronounced during patients’ early contacts with the
healthcare system.
KEY WORDS: HIV testing; provider education; sustainability; VA
hospitals.
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INTRODUCTION
There is a growing literature on the types of interventions
required to improve healthcare quality1. To reap long-term
benefits, the gains brought about by such programs must be
sustained beyond the initial interventional period. However,
achieving sustainability (i.e., the routinization and institution-
alization of improved processes), is difficult and may be
dependent on characteristics of the intervention that are not
examined during the trial that demonstrates effectiveness.
Sustainability is not often studied, and when it is, the results
are often disappointing2–4.
Herein we report on the sustainability of a successful
intervention to increase HIV testing. The clinical benefits of
identifying and treating asymptomatic human immunodefi-
ciency virus (HIV) infected individuals are firmly established
and more cost-effective than many other general population
preventive services5–14. However, 21% of the 1.1 million HIV-
infected persons in the United States remain undiagnosed15.
Similarly, only 30% to 50% of Veterans Administration (VA)
patients with known, documented risk factors for HIV infection
have been tested16,17. Therefore, we previously implemented a
multi-modal intervention based upon computerized decision
support, provider education and feedback, and organizational
changes that significantly increased HIV testing rates in at-risk
individuals who receive care at VA medical facilities18. Over a
one-year period, implementation of this program increased the
cumulative rate of ever being tested for HIV from 20.1% to
53.7% (p<0.001). In contrast, there was no change in three
control facilities.
Once the interventional year was over, we turned project
responsibility over to preexisting primary care clinical leader-
ship. This leadership chose to dramatically reduce the labor-
intensive provider education campaign and merged what little
that remained into routine clinical management (e.g. weekly
staff meetings). They did, however, continue the largely “fixed”
changes in the systems infrastructure for HIV testing, which
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required substantially less support to maintain (i.e. the
computerized decision support, feedback reports, and mainte-
nance of organizational changes). We now report on the
intervention’s sustainability in the second, sustainability year
of this project.
METHODS
As previously described18, the intervention program was put in
place for one year in two of the five geographically separate VA
regional healthcare systems (HCS) in southern Nevada and
California. HCS A and B were comprised of 12 and five sub-
facilities, respectively, in which primary care were provided by
mixtures of academic and non-academic staff physicians,
postgraduate medical trainees and mid-level providers. This
study was approved by the appropriate institutional review
boards.
In brief, the components of the intervention were:
1.) A continuously updated, electronic clinical reminder that
identifies patients at increased risk for HIV infection and
encourages providers to offer HIV testing to such indivi-
duals. This reminder is triggered by HIV risk factors
available in the VA electronic medical record. These
include evidence of Hepatitis B or C infection, illicit drug
use, sexually transmitted diseases, homelessness, and
Hepatitis C risk factors18. Once triggered, the reminder
was resolved by ordering an HIV test, recording the result
of an HIV test performed elsewhere, or indicating that the
patient was not competent to consent to testing or refused
HIV testing. Once resolved, the reminder was no longer
triggered.
2.) An audit-feedback system: Providers were given quarterly
reports of clinic-level HIV testing performance19.
3.) The reduction of organizational barriers: Under federal
laws specific to the VA, written, informed consent and pre-
test HIV counseling have been required for all HIV tests20.
To expedite this process we encouraged nurse-based
rather than physician-based pre-test counseling, use of
streamlined HIV counseling, and both telephone notifica-
tion and brief post-test counseling after negative HIV test
results18,21.
4.) A provider education (activation) program: This included
academic detailing, social marketing, and educational
materials22,23. The academic detailing component in-
volved regular informal discussions by project staff to
encourage providers to prioritize the performance of HIV
testing24,25. Social marketing involved having physician
and nursing clinical opinion leaders encourage HIV
testing by primary care healthcare providers26. Finally,
we developed and distributed educational hand-outs,
pocket cards and posters to promote HIV testing and
increase provider comfort and abilities to provide pre- and
post-test HIV counseling.
All aspects of the program were implemented in the first
month of the intervention year at HCS A and HCS B and
maintained during the subsequent 11 months. In support of
the provider education program, members of the study team
made frequent visits to the clinics to informally promote HIV
testing in one-on-one ad hoc meetings with primary care
providers. In addition, senior members of the study team
regularly attended clinic and facility-wide meetings of primary
care physicians, nurses and clinic leadership to promote HIV
testing.
The study team did not participate in provider education
activities during the second (sustainability) year of the study
and instead fully transferred responsibility for this activity to
clinic leadership. Qualitative evaluation indicated that provid-
er education activities were much reduced and merged into
routine clinical management activities such as staff meetings.
Leadership did maintain other aspects of the intervention,
including quarterly feedback reports of the rate of HIV testing,
and the electronic clinical reminder. Organizational changes
that had eased the documentation requirements for HIV
testing and broadened the number of people authorized to
initiate testing and counseling persisted. Distribution of
educational activities, pocket cards and handouts continued
at a reduced rate
Our primary analytical goal was to assess the trajectory of
the monthly rate of HIV testing during the intervention and
sustainability years. In addition, we assessed changes in the
proportion of patients who agreed to be tested.
Data sources. We obtained administrative and clinical data,
including patient demographics, laboratory tests, diagnostic
codes and health factors of the inpatient and outpatient
encounters from August 2004 to July 2007 from a pre-
existing regional VA database18. The medical records were
linked across the data files by encrypted identifiers.
Study population. We evaluated outcomes during clinical visits
of patients who were identified as being at-risk for HIV
infection but had not been offered HIV testing (i.e., the HIV
Testing Clinical Reminder had been previously been resolved).
Visits by eligible patients were removed from the database
subsequent to the month during which the reminder was
resolved.
Statistical methods. To assess the adjusted rates of HIV testing
and refusal, we performed logistic regression analyses in which
the unit of analysis was the patient who was seen at the VHA
facilities in each month, had HIV risk factors, but the HIV
Testing Clinical Reminder had not previously been resolved.
The dependent variables were performance of HIV testing and
documentation of patient refusal to be tested. The independent
variables included patient demographic and clinical factors
such as age, race and ethnicity, marital status, lack of
housing, co-payment status, being at-risk for hepatitis C,
hepatitis C infection, hepatitis B infection, illicit substance
use and sexually transmitted diseases18. The two VHA
healthcare systems comprised of 17 facilities where the
patients were seen. To adjust for any systemic effects on
patient likelihood of accepting or refusing HIV testing, we
included facility-level annual patient loads and baseline HIV
testing rates in the pre-intervention period as independent
variables. Finally, we adjusted the covariance of the regression
model for patient clustering within facilities using the
Generalized Estimating Equation method. The data analysis
was generated using SAS v9.1 proc genmod (SAS version 9.1.
SAS Institute, Cary, NC, USA).
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RESULTS
Table 1 compares the demographic features and factors of
patients with known risk for HIV infection who received care in
the intervention and sustainability years. In the sustainability
year, at-risk patients were somewhat younger and less often
married. This largely represents an influx of veterans from
recent military campaigns into VA care27–30. Otherwise there
were no meaningful differences in demographic and clinical
characteristics between the two years. The number of patients
in the sustainability year was lower than in the intervention
year as all patients in whom the HIV Testing Clinical Reminder
was resolved in the intervention year were excluded from the
analyses of the sustainability year.
We previously reported that our multi-modal intervention
more than doubled the rate of HIV testing rates among at-risk
individuals18. The percentage of at-risk patients who received
an HIV test was 11.1% in the intervention year versus 5.0% in
the year prior to the intervention (p<0.001). In the sustain-
ability year, 11.6% of at-risk patients were tested. To better
assess whether this result represented actual sustainability of
the intervention, we assessed the trajectory of the monthly HIV
testing rates31,32. This rate increased from 2% at baseline
(prior to implementation of the program) to 6% in month 12
(Fig. 1). Although the monthly testing rate declined in the
sustainability year, the rate in month 24 remained more than
twice the baseline rate (4% versus 2%). These results were
consistent across all patient subgroups (data not shown).
As only patients in whom the HIV Testing Clinical Reminder
remained unresolvedwere eligible for testing in the sustainability
year, the previous analyses are susceptible to bias from differ-
ences in system-, provider- or patient-level characteristics for
patients in whom the reminder was or was not resolved in the
intervention year. To reduce this bias, we analyzed HIV testing
rates by the order of visits since the start of the intervention
period (i.e. first visit, second visit, etc.). This analysis was
prompted by discussions with providers which indicated that a
more comprehensive approach to detecting undiagnosed disease
is taken in new patients. As shown on Figure 2a, the HIV testing
rate was consistently greatest on a patient’s first visit during the
study period (i.e., on the first possible exposure to the interven-
tion). For such patients, the testing rate increased from 2% at
baseline (pre-intervention) to 6% onmonth 1; the rate continued
to increase throughout the 24-month observation period. For
each subsequent visit, the magnitude of the increase in the HIV
testing rate was less than for patients having their first visit, but
remained greater than during the prestudy period for patients
Table 1. Patient Demographic and Clinical Characteristics
Characteristics 1st year 2nd year
N 29885 18486
Age (%)
• 18–30 4.4 7.3
• 31–50 16.5 21.5
• 51–64 42.9 45.1
• 65+ 36.2 26.1
Race/ethnicity (%)
• Caucasian 17.8 16.1
• African American 8.8 9.6
• Hispanic 3.6 3.4
• Asian, Native American 8.0 6.5
• Missing 61.8 64.4
Marital status (%)
• Single 23.1 27.1
• Married 35.7 31.1
• Widow/divorced/separated 41.3 41.7
Low income (%) 69.8 72.6
Risk factors (%)
• Hepatitis C infection 18.7 23.4
• Hepatitis B infections 12.5 13.4
• Prior sexually transmitted disease 4.1 5.2
• History of substance abuse 14.7 19.3
• History of homelessness 18.1 22.7
• Presence of risk factors for HCV infection 66.9 56.2
Patients were included if they had identified risk factors for HIV infection,
were not known to be HIV-infected and had no documentation of
previously having had an HIV test, refusing an HIV test or being
incompetent to consent to HIV testing.
Figure 1. Adjusted HIV testing rates among all patients with
identified risk factors for HIV infection. The active intervention
period started in study month one and lasted through study month
12. The sustainability period started in study month 13.
Figure 2. (a). Adjusted HIV testing rates among patients as
stratified by outpatient study visit number. The starting period for the
strata are offset at monthly intervals as very few patients had more
than one visit per month. (b). Proportion of outpatient visits grouped
by visit number.
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having their second to fourth visits. Time series analyses
demonstrated that the probability of being tested increased over
time for patients having their second or third visits. Minimal
increases were seen on the fourth visit and the testing rate on the
fifth and later visits did not increase. Over time the proportion of
patients being seen on their first to third visits decreased while
the proportion being seen on visit number four and greater
increased (Fig. 2b). This change in patient distribution explained
the attenuation of the rate of HIV testing in the overall popula-
tion. Further analyses did not identify any demographic, clinical
or facility characteristics that differed between persons who were
or were not tested for HIV by their fourth visit (data not shown).
As discussed inMETHODS, the HIV Testing Clinical Reminder
can be resolved byperforming anHIV test or bydocumenting that
the patient refused to be tested. While allowing for patient choice
with respect to HIV testing, minimization of the refusal rate is an
important goal; once “refused” is selected, the HIV Testing
Clinical Reminder did not promptproviders to re-offerHIV testing
during future visits. However, we hypothesized that some
“refusals” might actually reflect provider discomfort offering an
HIV test33,34, and therefore that the refusal rate might decrease
as providers gained more HIV testing experience.
We found that there was a substantial, continuous decrease
in the HIV test refusal rate (Fig. 3). The net result was that
among persons in whom the HIV Testing Clinical Reminder
was resolved, the likelihood that reminder resolution resulted
in HIV testing increased from 17% of all reminder responses in
the first month of the intervention to 60% in the final month.
DISCUSSION
We previously demonstrated that implementation of an inte-
grated package of quality improvement interventions that
utilizes decision support, a provider education (activation)
campaign, feedback reports and organizational changes more
than doubled HIV testing rates for at-risk individuals18. These
results were robust with dramatic increases in the likelihood of
being tested for HIV being observed across patient-level,
provider-level and subfacility-level factors. Furthermore, the
fraction of HIV test results that were positive remained
constant (0.45%) and well within the range at which HIV
testing costs less than $50,000 per quality-adjusted life year
when societal benefits of testing are considered6.
We now report on the sustainability of this program during
the twelve-month period after overall responsibility for the
interventional program was transferred to preexisting clinical
management, who chose to greatly deintensify the provider
education campaign and other labor and time-intensive
aspects of the intervention18,35. Remarkably, we found that
the rate of HIV testing continued to increase for patients
making their first, second or third visits during the sustain-
ability period. These results indicate that despite the de-
emphasis of the provider education campaign, when the
frequency of medical contact is considered, the program’s
impact on HIV testing rates was fully sustainable. The
observation that overall testing rates declined was related to
the changing make-up of the study population as patients with
their first through third visits accounted for 100% of the study
population in month 1, 54% of the population in month 12 and
41% of the population in month 24.
We also found that the rate at which patients refused HIV
testing decreased over time. Correspondingly, the likelihood of
having the HIV Testing Clinical Reminder being resolved by
HIV testing increased. These results suggest that providers
became more proficient at offering and discussing HIV tests
and may have integrated HIV testing into their normal
practice. Others have observed that normalization of HIV
testing is associated with increased patient acceptance of
testing36,37.
The importance of reporting the sustainability of health care
interventions and of choosing appropriate measurement metrics
is receiving increasing attention32. Our results indicate that
assessments of the sustainability of the outcome of an inter-
vention are critically dependent on the mode of analysis. We
found that when applied to homogeneous patient population (as
defined by prior use of VA healthcare), increased HIV testing
rates were sustained after de-emphasis of the provider educa-
tion campaign and continued to increase among patients newly
exposed to the intervention (Fig. 2a). This suggests that our
intervention has become part of the institutional culture of our
facility, does not overburden providers and fits the implement-
ing culture and variations of the patient population32.
Stratified analysis by the number of visits during each year
reveals that our intervention was least sustained among
established patients who had not previously been offered
testing. We conclude that interventions that aim to maximize
sustainability should consider a “tail” of provider education or
other components focused on patients who do not receive
recommended services on the first exposure. Also, further work
needs to be done to determine the determinants of repeated
non-performance. We believe that such failures are likely due to
systemic barriers or a lack of provider agreement/knowledge.
Notably, although theoretical38–40 and empirical observa-
tions22,23,41–43 demonstrate that the use of provider education
(or activation) campaigns are necessary to transform group
norms and maximize quality improvement, there is far less
literature regarding the importance of maintaining these activ-
ities to sustain whatever gains are achieved during their use32.
The strengths of our sustainability analysis include, as
recommended, use of a time-series analysis of monthly rates
of HIV testing which allowed us to better assess the trajectory
of HIV testing rates32,44. Furthermore, we examined the
effectiveness of the intervention in an unselected population
of at-risk veterans receiving care in a routine, real-world
clinical setting.
Figure 3. The vertical bars depict the adjusted rates at which
patients with HIV risk factors underwent tests or were stated to
refuse testing. The lines indicate the proportion of patients who
were offered HIV testing and then underwent testing.
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Limitations include the fact that the sustainability analysis
was done immediately after the withdrawal of study personnel
from active maintenance of the intervention. It is therefore
difficult to distinguish between lingering improvements from
the implementation and true persistence of effects from
institutionalization45. Moreover, this study was undertaken
within the quality improvement infrastructure in the VA, which
includes an electronic medical record, clinical reminder soft-
ware and familiarity with performance measurements. Al-
though such tools are increasingly common, this intervention
might not be generalizable to other healthcare systems.
Another limitation is that while sustainability can be defined
as continued use of the core elements of the interventions, and
persistence of improved performance32, we did not formally
evaluate the continued use of the core elements of the
interventions or their individual contributions to the success-
ful sustenance of the intervention. However, surveys of the two
HCSs involved in this project indicate that the organizational
changes that favor HIV testing and the HIV Testing Clinical
Software package have been maintained. Another limitation is
that there was still room for improvement and it is unknown
whether the rates of HIV testing would have increased further
had the provider activation campaign been continued. Fur-
thermore, while guidelines now recommend that all patients be
offered HIV testing and that yearly testing be offered to persons
who continue to engage in high risk activities14,46–48, this
intervention was targeted to ensure one-time testing in
patients with known risk factors. This strategy was purposely
undertaken to prioritize testing for patients at the highest
known risk for HIV infection and in deference to concerns that
a program to promote HIV testing in all patients would be
impractical in the VA as long as written informed consent was
required for testing. Finally, the achieved rate of HIV testing
remained less than desired. It will be important to determine
the effect of removal of the written informed consent require-
ment for VA HIV testing in August 2009 on the rates of HIV
testing49.
In conclusion, we found that when assessed in homoge-
neous patient populations, the impact of implementation of
the coordinated use of a computerized clinical reminder,
feedback reports, provider education and organizational
change is sustainable after cessation of external support of
the provider education component. Maintenance of the gains
after withdrawal of support by the research team suggests that
the organizational and behavioral changes that led to the
enhanced performance of HIV testing were successfully insti-
tutionalized. These findings have substantial implications for
the assessment and sustenance of quality improvements
programs for clinical preventive services and beyond.
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